Azstarys

The typical dosing of Azstarys is one capsule taken once daily in the morning. The capsule can be swallowed whole or opened, and the contents sprinkled on a small amount of applesauce or yogurt if swallowing capsules is difficult. It is important to take Azstarys at the same time each day, with or without food, to maintain consistent blood levels and symptom control.

Azstarys is contraindicated in patients with known hypersensitivity to serdexmethylphenidate, dexmethylphenidate, or any of the other components of the medication. It should not be used in patients with significant cardiovascular disease, moderate to severe hypertension, hyperthyroidism, or in those who are currently taking or have recently taken monoamine oxidase inhibitors (MAOIs) within the last 14 days. Caution is advised in patients with a history of substance abuse, as Azstarys has a high potential for abuse and dependence.

Patients taking Azstarys should be advised to take the medication exactly as prescribed and not to share it with others, especially those with a history of substance abuse. It is important to monitor for any changes in behavior, mood, or mental health, especially during the initiation of treatment or dose adjustments. Patients should also be aware of the potential cardiovascular effects, such as increased heart rate and blood pressure, and should report any significant changes to their healthcare provider. Regular follow-up appointments are necessary to monitor the effectiveness of the medication and to make any necessary dosage adjustments.

Common side effects of Azstarys include decreased appetite, insomnia, stomach pain, headache, and nausea. Some patients may also experience anxiety, irritability, or weight loss.

Serious side effects, though rare, can include cardiovascular events such as increased blood pressure, heart palpitations, and in rare cases, sudden death in patients with pre-existing heart conditions. Other serious side effects include the potential for psychiatric symptoms such as new or worsening aggression, hostility, or suicidal thoughts. Patients should contact their healthcare provider if they experience any severe or persistent side effects.

Azstarys carries the risk of potential abuse and dependence, which is why it is classified as a Schedule II controlled substance. It should be used with caution in patients with a history of substance abuse or those with underlying psychiatric conditions, as it may exacerbate certain mental health symptoms. There is also a risk of cardiovascular side effects, particularly in patients with pre-existing heart conditions. Therefore, a thorough cardiovascular evaluation should be performed before initiating treatment, and ongoing monitoring is recommended.

Azstarys may interact with other medications that affect the central nervous system, such as antidepressants, antipsychotics, and other stimulant medications. It can also interact with MAOIs, leading to potentially dangerous increases in blood pressure and other adverse effects. Patients should inform their healthcare provider of all medications and supplements they are taking to avoid potential interactions. Additionally, the use of alcohol should be discussed with the healthcare provider, as it can enhance certain side effects of the medication.

Alternative treatments for ADHD include other stimulant medications such as methylphenidate (Ritalin, Concerta) or amphetamine-based drugs (Adderall, Vyvanse). Non-stimulant alternatives include atomoxetine (Strattera), guanfacine (Intuniv), and clonidine (Kapvay). Behavioral therapies and lifestyle changes are also important components of ADHD management. The choice of alternative treatment will depend on the patient’s specific symptoms, medical history, and response to previous treatments.